|
Baxter Commences First-Of-Its-Kind, Phase II Adult Stem Cell Trial in U.S. in Patients With Severe Coronary Artery Disease DEERFIELD, Ill., March 7 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced that it has initiated the first human Phase II adult stem cell therapy trial in the U.S (more)
|